Sytrinol, a patented formula derived from citrus and palm fruit extracts, is licensed exclusively to Chicago-based SourceOne Global Partners. Source Naturals, which distributes more than 500 health and wellness supplements in the US, will add the new product to its Cholesterol Rescue range, making it available as a stand alone product for the first time in the US.
LaVonne Whitley, marketing director for Source Naturals, said: "Marketing Sytrinol supports our long-standing tradition of being first to market with innovative, science-based products."
Sytrinol is composed of polymethoxylated flavones and tocotrienols. Clinical trials have demonstrated that it acts synergistically to reduce total cholesterol, LDL cholesterol and triglycerides by 23 per cent, 21 per cent and 26 per cent respectively. It is thought to have no known side effects.
The risk for a fatal heart attack is thought to be about five times higher in people with a cholesterol level of 300 mg/dL or more than in those with a cholesterol level below 200 mg/dL.
Source Naturals will market Sytrinol through both retailer and consumer campaigns. The product will be sold in 30 and 60 tablet bottles at the retail price of $14.50 and $25.98, respectively.